Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether hepatitis B immunoglobin can be discontinued early after hepatitis B virus (HBV) induced liver transplantation and be replaced by the nucleoside analo...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
HepNet Study House, German Liverfoundation
Collaborators
NCT06472973 · Alcohol Associated Liver Disease, Liver Transplantation
NCT05330923 · Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and more
NCT06092333 · Chronic Hepatitis B
NCT04914611 · Hepatitis B
NCT07588854 · Chronic Liver Disease (CLD), Liver Fibrosis
University Clinic Essen
Essen
Hannover Medical School
Hanover
University Hospital Heidelberg
Heidelberg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions